Instead, a thorough clinical evaluation of aggressiveness is strongly recommended on a case-by-case basis, although accurate tumor subtyping (including an assessment of the tumor proliferative potential by mitotic count and Ki-67 index, as well as MRI findings and/or intraoperative impression) remains essential [11]. Here, MKI67 is linked to neoplasm.